SEC Form 4 · accession 0001144204-15-022015
Amarantus Bioscience Holdings, Inc. · AMBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Edward Farrell
Officer — CFO
Period of report
Apr 9, 2015
Accepted (ET)
Apr 9, 2015 · 3:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001424812
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 9, 2015 | P | 200,000 | $0.0499 | A | 333,333 | D |
Table II — derivative securities
No Table II lines on this filing.